IFAM
GBT

Institutional & Family Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Institutional & Family Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21
Closed -$1K – 918
2020
Q2 		$1K Buy
21
+6
+40% +$412 ﹤0.01% 823
2020
Q1 		$1K Hold
15
– – ﹤0.01% 794
2019
Q4 		$1K Hold
15
– – ﹤0.01% 840
2019
Q3 		$1K Sell
15
-3
-17% -$156 ﹤0.01% 817
2019
Q2 		$1K Buy
+18
New +$1.03K ﹤0.01% 828

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Institutional & Family Asset Management's GBT Position: Q3 2020 in Review

Institutional & Family Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 21 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in GBT in Q2 2019 and held it in 5 quarters. The position peaked at $1K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Institutional & Family Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 21 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 5 quarters.
  • Institutional & Family Asset Management's Global Blood Therapeutics, Inc. position peaked at $1K in Q2 2020.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Institutional & Family Asset Management's 13F filing for Q3 2020, filed 30 Oct 2020.